Literature DB >> 17938426

Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Douglas A Corley1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17938426      PMCID： PMC2095675          DOI： 10.1136/gut.2007.124255

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  30 in total

1.  Anthropometric correlates of intragastric pressure.

Authors:  Hashem B El-Serag; Thomas Tran; Peter Richardson; Gulchin Ergun
Journal:  Scand J Gastroenterol       Date:  2006-08       Impact factor: 2.423

2.  Abdominal obesity and the risk of Barrett's esophagus.

Authors:  Hashem B El-Serag; Peter Kvapil; Joan Hacken-Bitar; Jennifer R Kramer
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

3.  Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

4.  Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus.

Authors:  Catherine de Martel; Thomas D Haggerty; Douglas A Corley; Joseph H Vogelman; Norman Orentreich; Julie Parsonnet
Journal:  Am J Gastroenterol       Date:  2007-03-22       Impact factor: 10.864

Review 5.  Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Ai Kubo
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

Review 6.  Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

7.  Adiponectin as a growth inhibitor in prostate cancer cells.

Authors:  Jeffrey D Bub; Toshiaki Miyazaki; Yoshiki Iwamoto
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

8.  Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study.

Authors:  Audrey H H Merry; Leo J Schouten; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Gut       Date:  2007-03-02       Impact factor: 23.059

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

Review 10.  Leptin as a proinflammatory cytokine.

Authors:  Graham M Lord
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580
View more
  5 in total

1.  Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.

Authors:  Lucy M Almers; James E Graham; Peter J Havel; Douglas A Corley
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-26       Impact factor: 11.382

2.  Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.

Authors:  Stuart J Thomas; Lucy Almers; Jennifer Schneider; James E Graham; Peter J Havel; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2015-09-22       Impact factor: 3.199

3.  Esophageal malignancy: a growing concern.

Authors:  Jianyuan Chai; M Mazen Jamal
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 4.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

Review 5.  The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab.

Authors:  Zhiheng Chang; Tong Dang; Xianmei Meng; Jianyuan Chai
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.